Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 32, 2020 - Issue 7
139
Views
2
CrossRef citations to date
0
Altmetric
Articles

Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris

ORCID Icon, , , , , , , , , , & show all
Pages 811-817 | Received 20 Dec 2018, Accepted 15 Jul 2019, Published online: 21 Aug 2019

References

  • Babiker, A. G., Emery, S., Fätkenheuer, G., Gordin, F. M., Grund, B., Lundgren, J. D., … Vjechaj, M. J. (2013). Considerations in the rationale, design and methods of the strategic timing of antiretroviral treatment (START) study. Clinical Trials, 10(1 Suppl.), S5–36. doi: 10.1177/1740774512440342
  • Bärnighausen, T., Tanser, F., Dabis, F., & Newell, M.-L. (2012). Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: The experimental evidence. Current Opinion in HIV and AIDS, 7(2), 140–150. doi: 10.1097/COH.0b013e32834fc1df
  • Boyer, V., Vilotitch, A., Panjo, H., Sagaon-Teyssier, L., Marcellin, F., Dray-Spira, R., … Bajos, N. (2016). Heterosexual practices of women and men living with HIV attending hospital outpatient services (ANRS-VESPA2 survey): a French comparative study with the general population (CSF survey). AIDS Care, 28(11), 1345–1354. doi: 10.1080/09540121.2016.1191600
  • Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505. doi: 10.1056/NEJMoa1105243
  • Dixneuf, Marc, & Treatment as Prevention: connaissance, représentations et comportements. (2018). Retrieved from https://public.weconext.eu/trt5/2016-06-10/video_id_006/index.html.
  • Dombrowski, J. C., Harrington, R. D., & Golden, M. R. (2013). Evidence for the long-term stability of HIV transmission-associated sexual behavior after HIV diagnosis. Sexually Transmitted Diseases, 40(1), 41–45. doi: 10.1097/OLQ.0b013e3182753327
  • Giami, A., & Spencer, B. (2004). Les objets techniques de la sexualité et l’organisation des rapports de genre dans l’activité sexuelle: contraceptifs oraux, préservatifs et traitement des troubles sexuels. Revue D'Épidémiologie et de Santé Publique, 52(4), 377–387. doi: 10.1016/S0398-7620(04)99067-0
  • Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. The Lancet, 373(9657), 48–57. doi: 10.1016/S0140-6736(08)61697-9
  • Grinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., … Cohen, M. S. (2014). Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial. The Lancet Infectious Diseases, 14(4), 281–290. doi: 10.1016/S1473-3099(13)70692-3
  • Hallett, T. B., Smit, C., Garnett, G. P., & de Wolf, F. (2011). Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Sexually Transmitted Infections, 87(1), 17–21. doi: 10.1136/sti.2010.042622
  • Kankou, J. M., Bouchaud, O., Lele, N., Bourgeois, D., Spire, B., Carrieri, M. P., … ANRS-VIHVO study group. (2017). Factors associated with HIV status disclosure in HIV-infected sub-Saharan migrants living in France and successfully treated with antiretroviral therapy: Results from the ANRS-VIHVO study. Journal of Immigrant and Minority Health, 19(4), 843–850. Retrieved from http://link.springer.com/10.1007/s10903-016-0423-1
  • Knight, R., Small, W., Thomson, K., Gilbert, M., & Shoveller, J. (2016). Implementation challenges and opportunities for HIV treatment as prevention (TasP) among young men in Vancouver, Canada: A qualitative study. BMC Public Health, 16(1). Retrieved from http://www.biomedcentral.com/1471-2458/16/262 doi: 10.1186/s12889-016-2943-y
  • Lert, F., Sitta, R., Bouhnik, A.-D., Dray-Spira, R., & Spire, B. (2010). HIV-positive men who have sex with men: Biography, diversity in lifestyles, common experience of living with HIV. ANRS-EN12 VESPA study, 2003. AIDS Care, 22(1), 71–80. doi: 10.1080/09540120903012544
  • Lorente, N., Demoulin, B., Marcellin, F., Dray-Spira, R., & Spire, B. (2016). COMPORTEMENTS SE xu ELS DES PERSONNES VIVANT AVEC LE VIH EN F RANCE EN 2011: PREMIERS R éSuLTATS DE L ‘EN quê TE ANRS-V ESPA 2 // S ExUAL BEHAVIOURS OF p EO pLE LIVING WITH HIV IN FRANCE IN 2011: FIRST RESULTS OF THE ANRS-VESpA2 STUDy. Retrieved from http://invs.santepubliquefrance.fr/beh/2013/27/pdf/2013_26-27_3.pdf
  • Magidson, J. F., Li, X., Mimiaga, M. J., Moore, A. T., Srithanaviboonchai, K., Friedman, R. K., … Safren, S. A. (2016). Antiretroviral medication adherence and amplified HIV transmission risk among sexually active HIV-infected individuals in three diverse international settings. AIDS and Behavior, 20(4), 699–709. doi: 10.1007/s10461-015-1142-7
  • Martin, J. N., Roland, M. E., Neilands, T. B., Krone, M. R., Bamberger, J. D., Kohn, R. P., … Katz, M. H. (2004). Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS, 18(5), 787–792. doi: 10.1097/00002030-200403260-00010
  • McNeil, R., Kerr, T., Coleman, B., Maher, L., Milloy, M. J., & Small, W. (2017). Antiretroviral therapy interruption among HIV postive people who use drugs in a setting with a community-wide HIV treatment-as-prevention initiative. AIDS and Behavior, 21(2), 402–409. doi: 10.1007/s10461-016-1470-2
  • Rapport-activite-2014.pdf. (2019). Retrieved from https://www.corevih-idfnord.fr/documents/bilans/Rapport-activite-2014.pdf
  • Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., … Lundgren, J. (2016). Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner Is using suppressive antiretroviral therapy. JAMA, 316(2), 171–181. doi: 10.1001/jama.2016.5148
  • Rojas Castro, D., Fugon, L., Bourgeois-Fisson, E., Le Gall, J. M., Barbier, F., & Spire, B. (2012). The “Swiss Statement”: Who knows about it? How do they know? What are its effects on people living with HIV/AIDS? AIDS Care, 24(8), 1013–1019. doi: 10.1080/09540121.2012.668169
  • Tabernilla, A., & Poveda, E. (2015). The START Trial: Definitive evidence to treat all HIV-positive persons regardless of CD4 counts. AIDS Reviews, 17(3), 187.
  • Vernazza, P., Hirschel, B., Bernasconi, E., & Flepp, M. (2008). HIV transmission under highly active antiretroviral therapy. The Lancet, 372(9652), 1806–1807. doi: 10.1016/S0140-6736(08)61753-5
  • Young, I., & McDaid, L. (2014). How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS and Behavior, 18(2), 195–216. doi: 10.1007/s10461-013-0560-7
  • Zakher, B., Blazina, I., & Chou, R. (2014). Association between knowledge of HIV-positive status or use of antiretroviral therapy and high-risk transmission behaviors: Systematic review. AIDS Care, 26(4), 514–521. doi: 10.1080/09540121.2013.832723

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.